Key facts: The global GLP-1 market is projected to exceed $100 billion by 2030 Novo Nordisks market cap surged significantly due to Ozempic & Wegovy demand Eli Lillys Mounjaro showed ~20%+ average weight loss in clinical trials Supply shortages have been reported globally due to high demand Whats driving this growth
By following strict safety and ethical guidelines, PT-141 can provide valuable insights into sexual behavior, CNS signaling, and motivational neuroscience
Aligned with our Leadership Principles, Ascendis Pharma places strong emphasis on developing leadership capabilities at all levels of the organization, recognizing this as essential to fostering a motivated and engaged workforce
Therefore, physicians cannot rely solely on classification of antiarrhythmic agents in this manner when determining the best drug strategy for each patient
02.21.25 Semaglutide removed from FDA drug shortage list Semaglutide injections were removed from the FDA Drug Shortages List
adults report taking GLP-1 medications like semaglutide and tirzepatide specifically for weight loss, according to a 2025 Gallup poll
